FDA Inspection 661070 — Changzhou Qianhong Biopharma Co., Ltd.
The FDA completed an inspection of Changzhou Qianhong Biopharma Co., Ltd. on Apr 30, 2010 in Changzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 30, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Changzhou (China)